Dopamine promotes EMT and stemness of HCC by inducing the expression of SULT1A3/4 (Zou et al., 2017) and may provide a new strategy for the clinical targeted therapy of HCC. The gene discussed is SULT1A3; the disease is hepatocellular carcinoma.